Question 1

What is PeptideDoc?

Accepted Answer

PeptideDoc is a physician-led medical wellness practice providing personalized care in peptide therapy, medical weight management, metabolic health, hormone-related concerns, and integrative wellness. Treatment recommendations are based on an individual medical evaluation, health history, clinical goals, and medical appropriateness.

Question 2

Who leads PeptideDoc?

Accepted Answer

PeptideDoc is led by Dr. Saul Maslavi, MD. The practice is designed around physician evaluation, individualized treatment planning, and ongoing medical oversight rather than a one-size-fits-all wellness program.

Question 3

Where is PeptideDoc located?

Accepted Answer

PeptideDoc's medical office is located at 4232 Francis Lewis Boulevard in Bayside, Queens, New York. The practice serves patients traveling from across New York City, Long Island, New Jersey, Connecticut, and the surrounding Tri-State area. Patients may travel to the Bayside office by car or regional rail connections, including the LIRR, NJ TRANSIT, and Metro-North.

Question 4

Is PeptideDoc a medical practice or a med spa?

Accepted Answer

PeptideDoc is positioned as a physician-led medical wellness practice. Medical evaluation and clinical judgment guide treatment decisions, and prescription therapies are considered only when medically appropriate.

Question 5

Does PeptideDoc offer telemedicine consultations?

Accepted Answer

Virtual consultations may be available when clinically appropriate and permitted. Some treatments may require laboratory testing, records review, or an in-person evaluation before a treatment plan can be finalized.

Question 6

How is PeptideDoc different from large national telehealth platforms?

Accepted Answer

PeptideDoc focuses on a high-touch physician-led model. Rather than relying solely on standardized online treatment pathways, recommendations are based on the patient's medical history, goals, clinical evaluation, laboratory findings when appropriate, and physician judgment.

Question 7

What happens during my first PeptideDoc consultation?

Accepted Answer

The initial consultation is used to understand your health goals, medical history, current medications, relevant symptoms, previous treatments, and other clinical factors. The physician then determines whether additional testing or a treatment plan may be appropriate.

Question 8

How much is the initial consultation?

Accepted Answer

The initial consultation fee is $175.

Question 9

Is the $175 consultation fee credited toward treatment?

Accepted Answer

If, following medical evaluation, you are determined to be an appropriate candidate and choose to proceed with peptide therapy, the full $175 consultation fee is credited toward your peptide purchase. If Dr. Saul Maslavi determines that peptide therapy would not be medically appropriate for you, the $175 consultation fee is refunded. Scheduling a consultation does not guarantee eligibility, a prescription, or any specific treatment.

Question 10

Does paying for a consultation guarantee that I will receive medication?

Accepted Answer

No. Payment for a consultation does not guarantee a prescription, peptide therapy, weight-loss medication, or any other treatment. Treatment decisions are based on medical evaluation, clinical appropriateness, applicable prescribing requirements, and physician judgment.

Question 11

Will I need laboratory testing?

Accepted Answer

Some patients may require laboratory testing depending on their medical history, symptoms, goals, and the treatment being considered. Testing requirements are determined individually.

Question 12

How quickly can treatment begin after my consultation?

Accepted Answer

Timing varies by patient. Some treatment plans can be discussed during the initial consultation, while others may require laboratory results, medical-record review, additional evaluation, or follow-up before treatment begins.

Question 13

How often will my treatment plan be reviewed?

Accepted Answer

Follow-up frequency depends on the treatment and the patient's individual needs. Monitoring may include review of symptoms, treatment response, side effects, laboratory findings, and adjustments to the treatment plan.

Question 14

What should I prepare for my consultation?

Accepted Answer

Be prepared to discuss your health goals, medical history, current medications and supplements, previous treatments, allergies, and any relevant recent laboratory results. Do not send sensitive medical information through general website contact channels.

Question 15

What are peptides?

Accepted Answer

Peptides are short chains of amino acids that act as signaling molecules in many biological processes. Certain peptide-based medications have established medical uses, while other peptide compounds may be investigational, unapproved, or subject to regulatory limitations.

Question 16

What is peptide therapy?

Accepted Answer

Peptide therapy refers broadly to the use of peptide-based medications or compounds in medical care. Whether a specific therapy is appropriate depends on the patient's health history, goals, available evidence, regulatory status, and physician evaluation.

Question 17

How does PeptideDoc determine whether peptide therapy is appropriate?

Accepted Answer

The decision begins with a medical consultation. The physician considers the patient's goals, medical history, medications, relevant laboratory findings, potential risks, alternatives, and the regulatory status of the therapy being considered.

Question 18

Is peptide therapy right for everyone?

Accepted Answer

No. Some patients may not be appropriate candidates because of medical conditions, medications, pregnancy status, treatment risks, lack of supporting evidence, or other clinical considerations.

Question 19

Why does physician supervision matter with peptide therapy?

Accepted Answer

Peptide-based treatments may affect important biological pathways and can involve risks, contraindications, drug interactions, and monitoring requirements. Physician oversight helps determine whether a therapy is appropriate and how a patient should be monitored.

Question 20

Are there risks or side effects associated with peptide therapy?

Accepted Answer

Yes. Risks vary significantly depending on the specific medication or compound. Potential side effects, contraindications, expected benefits, uncertainties, and alternatives should be discussed with the physician before treatment.

Question 21

How are PeptideDoc treatment plans personalized?

Accepted Answer

Treatment recommendations are individualized based on health history, clinical goals, medical evaluation, relevant laboratory findings, previous treatment response, and ongoing monitoring.

Question 22

Can peptide therapy be combined with medical weight management?

Accepted Answer

In some cases, peptide-based care may be considered as part of a broader physician-supervised wellness or weight-management plan. The combination depends on the individual patient and the treatments being considered.

Question 23

Does PeptideDoc offer medical weight management?

Accepted Answer

Yes. PeptideDoc provides physician-supervised medical weight-management consultations that may include evaluation of nutrition, lifestyle, metabolic factors, health history, laboratory findings, and medically appropriate treatment options.

Question 24

How is PeptideDoc's weight-management approach personalized?

Accepted Answer

The approach is based on the individual rather than a standardized program. The physician considers factors such as medical history, weight history, metabolic health, medications, lifestyle, goals, treatment response, and laboratory findings when appropriate.

Question 25

What are GLP-1 medications?

Accepted Answer

GLP-1–based medications are prescription drugs that affect pathways involved in appetite, blood glucose regulation, and other metabolic processes. Some medications in this class have FDA-approved indications for type 2 diabetes, chronic weight management, or both.

Question 26

What is the difference between semaglutide and tirzepatide?

Accepted Answer

Semaglutide and tirzepatide are different prescription medications with different mechanisms, approved products, indications, dosing schedules, side-effect profiles, and clinical considerations. A physician can determine whether either medication may be appropriate based on the patient's individual circumstances.

Question 27

Who may qualify for prescription weight-management medication?

Accepted Answer

Eligibility depends on factors including medical history, body mass index, weight-related health conditions, contraindications, current medications, prior treatment history, and the specific medication being considered.

Question 28

What happens if my weight loss plateaus?

Accepted Answer

Weight-loss plateaus are common. The physician may review nutrition, activity, sleep, medication response, adherence, metabolic factors, laboratory findings, and whether the current treatment plan remains appropriate.

Question 29

Are nutrition and lifestyle changes still important if I use medication?

Accepted Answer

Yes. Medical weight management generally works best when medication, when appropriate, is combined with sustainable nutrition, physical activity, sleep, behavior change, and ongoing clinical monitoring.

Question 30

How are patients monitored while using weight-management medication?

Accepted Answer

Monitoring may include weight trends, symptoms, medication tolerance, side effects, health goals, laboratory testing when appropriate, and adjustments to the treatment plan.

Question 31

Are all peptide therapies FDA approved?

Accepted Answer

No. FDA approval varies by medication and indication. Some peptide-based medications are FDA approved for specific uses, while other compounds may be investigational or unapproved. PeptideDoc should discuss the regulatory status of any therapy being considered before treatment.

Question 32

What is a compounded medication?

Accepted Answer

A compounded medication is prepared by a licensed compounder to meet a specific patient or clinical need. Compounded medications are not FDA approved, which means the FDA does not review them for safety, effectiveness, or quality before they are marketed.

Question 33

Are compounded medications the same as FDA-approved medications?

Accepted Answer

No. FDA-approved medications undergo the FDA's premarket review process. Compounded medications do not receive FDA approval and may be considered only when legally permitted and clinically appropriate.

Question 34

What is a 503B outsourcing facility?

Accepted Answer

A 503B outsourcing facility is a drug compounding facility that registers with the FDA and is subject to additional federal requirements, including current good manufacturing practice requirements and FDA inspection. Registration does not mean that the compounded medications produced by the facility are FDA approved.

Question 35

Why might a compounded medication be considered?

Accepted Answer

Compounding can serve an important medical need when an FDA-approved medication cannot meet a particular patient's needs or when other conditions permitted under federal law apply. The physician determines whether a compounded medication is appropriate for the individual patient.

Question 36

How does PeptideDoc discuss treatment risks and benefits?

Accepted Answer

Before treatment, patients should receive information about the intended purpose of the therapy, expected benefits, known risks, side effects, alternatives, uncertainties, regulatory status, and monitoring requirements.

Question 37

How are treatment concerns or side effects handled?

Accepted Answer

Patients should contact the practice if they experience concerning symptoms or possible side effects. Depending on the situation, the physician may recommend evaluation, treatment adjustment, discontinuation, testing, or other appropriate care.

Question 38

What is retatrutide?

Accepted Answer

Retatrutide is an investigational medication being studied for metabolic conditions including obesity. It is not currently an FDA-approved medication.

Question 39

Is retatrutide FDA approved?

Accepted Answer

No. Retatrutide is not FDA approved and has not been found by the FDA to be safe and effective for any condition.

Question 40

Can retatrutide be compounded?

Accepted Answer

No. The FDA states that retatrutide cannot be used in compounding under federal law.

Question 41

What are researchers studying retatrutide for?

Accepted Answer

Researchers are evaluating retatrutide in clinical trials for obesity and related metabolic outcomes. Research findings should not be interpreted as FDA approval or routine clinical availability.

Question 42

Does PeptideDoc currently offer retatrutide?

Accepted Answer

PeptideDoc follows applicable federal and state requirements. Investigational or unapproved products should not be presented as routinely available treatment when their use is not legally permitted.

Question 43

What is tesamorelin?

Accepted Answer

Tesamorelin is a prescription growth hormone–releasing factor analog. An FDA-approved tesamorelin product is indicated for reducing excess abdominal fat in adults with HIV-associated lipodystrophy.

Question 44

Is tesamorelin an FDA-approved weight-loss medication?

Accepted Answer

No. The FDA-approved tesamorelin labeling specifically states that it is not indicated for weight-loss management.

Question 45

Can tesamorelin change body composition?

Accepted Answer

Tesamorelin has an FDA-approved indication related to excess abdominal fat in adults with HIV-associated lipodystrophy. Whether it is appropriate for an individual patient depends on the indication, medical history, risks, and physician evaluation.

Question 46

What should patients know about Ipamorelin, CJC-1295, IGF-1 LR3, MOTS-C, and similar peptides?

Accepted Answer

Some peptides promoted in the wellness market are not FDA-approved medications and may have limited clinical evidence, uncertain safety profiles, regulatory restrictions, or compounding limitations. Patients should not assume that a peptide is safe, effective, or legally available simply because it is promoted online.

Question 47

Does PeptideDoc automatically recommend popular wellness peptides?

Accepted Answer

No. Treatment decisions should be based on medical evaluation, available evidence, regulatory status, patient-specific risks, and legal requirements rather than popularity or online trends.

Question 48

Why is regulatory status important when evaluating a peptide?

Accepted Answer

Regulatory status helps patients understand whether a product has undergone FDA review, whether it may legally be prescribed or compounded, and what is known about its safety, effectiveness, manufacturing quality, and approved indications.

Question 49

Can online peptide information be misleading?

Accepted Answer

Yes. Online marketing may blur the distinction between FDA-approved medications, compounded drugs, investigational products, research chemicals, and supplements. Patients should verify claims with a qualified medical professional and reliable regulatory sources.

Question 50

Does PeptideDoc evaluate hormone-related concerns?

Accepted Answer

Yes, when clinically appropriate. Hormone-related concerns may be evaluated as part of personalized wellness care based on symptoms, medical history, examination, laboratory testing, and physician assessment.

Question 51

Does a hormone-related symptom automatically mean I need hormone therapy?

Accepted Answer

No. Symptoms such as fatigue, weight changes, sleep problems, or changes in body composition can have many causes. Appropriate evaluation is needed before deciding whether hormone treatment is warranted.

Question 52

Can metabolic health affect weight, energy, and body composition?

Accepted Answer

Yes. Metabolic health can be influenced by factors including nutrition, activity, sleep, insulin sensitivity, medications, hormones, age, genetics, and underlying medical conditions.

Question 53

What is health optimization?

Accepted Answer

Health optimization is a broad approach that focuses on improving modifiable factors such as nutrition, physical activity, sleep, metabolic health, body composition, recovery, and preventive care while addressing medical conditions when appropriate.

Question 54

What should I look for when choosing a peptide clinic in the NYC Tri-State area?

Accepted Answer

Look for physician involvement, clear medical evaluation, transparent discussion of FDA and regulatory status, appropriate laboratory testing, individualized treatment decisions, ongoing monitoring, privacy protections, and clear information about where medications are dispensed.

Question 55

Why choose a physician-led peptide clinic?

Accepted Answer

Physician-led care provides medical evaluation before treatment, review of risks and contraindications, assessment of medications and health conditions, individualized treatment planning, and clinical follow-up.

Question 56

How is a physician-led practice different from a standardized online wellness program?

Accepted Answer

A physician-led practice can evaluate the patient's broader medical context and adjust recommendations based on clinical findings rather than relying primarily on standardized questionnaires or preset treatment pathways.

Question 57

Why does local physician oversight matter?

Accepted Answer

Local physician oversight can provide continuity of care, easier access to clinical follow-up, coordination of testing when needed, and a clearer relationship between the patient and the treating medical practice.

Question 58

Can I receive peptide or medical weight-management care in the NYC Tri-State area (NYC, NJ, CT)?

Accepted Answer

Yes. PeptideDoc provides physician-led medical wellness consultations for NYC Tri-State residents from its Bayside, NY office. Treatment availability depends on individual medical evaluation and applicable prescribing requirements.

Question 59

How do I schedule a consultation?

Accepted Answer

Patients can schedule a consultation through the PeptideDoc booking page at PeptideDoc.com.

Question 60

Who should I contact with consultation questions?

Accepted Answer

Consultation and physician-specific questions can be directed to drmaslavi@peptidedoc.com.

Question 61

Who should I contact for general PeptideDoc questions?

Accepted Answer

General inquiries can be sent to contactus@peptidedoc.com.

Question 62

Who should I contact for customer support?

Accepted Answer

Customer-support questions can be sent to support@peptidedoc.com.

Question 63

Who should I contact about privacy, HIPAA, or data-rights questions?

Accepted Answer

Privacy, HIPAA, and data-rights inquiries can be sent to privacy@peptidedoc.com.

Question 64

Who evaluates patients at PeptideDoc?

Accepted Answer

PeptideDoc uses physician-led evaluation to determine whether treatment is medically appropriate. Patients receive an individualized review of their medical history, health goals, current medications, and treatment needs before a treatment plan is recommended. Where appropriate, PeptideDoc also provides medication education, clinical monitoring, follow-up care, and RN-led injection training.

FAQ Peptide Therapy: Client FAQ

Ask PeptideDoc

About PeptideDoc

Consultations & Patient Care

Peptide Therapy

Medical Weight Management

FDA Status, Compounding & Safety

Retatrutide

Tesamorelin

Investigational or Unapproved Peptides

Hormone, Metabolic Health & Wellness

Choosing a Peptide or Wellness Clinic

Contact & Booking

Have Questions About Whether Treatment May Be Right for You?

Explore our services